Scarica l'app Stockscreener
7.87
3.20%
-0.26
Dopo l'orario di chiusura:
8.02
0.15
+1.91%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NEO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$8.13
Aprire:
$8.13
Volume 24 ore:
1.20M
Relative Volume:
0.49
Capitalizzazione di mercato:
$1.02B
Reddito:
$628.25M
Utile/perdita netta:
$-78.55M
Rapporto P/E:
-12.69
EPS:
-0.62
Flusso di cassa netto:
$-29.73M
1 W Prestazione:
-2.96%
1M Prestazione:
+19.15%
6M Prestazione:
-22.54%
1 anno Prestazione:
-50.19%
Intervallo 1D:
$7.81
$8.13
Intervallo di 1 settimana:
$7.81
$8.725
Portata 52W:
$4.72
$19.11
Neogenomics Inc Stock (NEO) Company Profile
Nome
Neogenomics Inc
Settore
Industria
Telefono
(239) 768-0600
Indirizzo
9490 NEOGENOMICS WAY, FORT MYERS, FL
Confronta NEO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
7.87 | 1.05B | 628.25M | -78.55M | -29.73M | -0.62 |
|
TMO
Thermo Fisher Scientific Inc
|
468.00 | 177.38B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
185.91 | 135.85B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
627.17 | 51.87B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
124.38 | 35.70B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
181.24 | 31.70B | 15.70B | 1.24B | 2.01B | 6.91 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-30 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-07-29 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | Iniziato | Guggenheim | Neutral |
| 2025-04-30 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | Downgrade | The Benchmark Company | Buy → Hold |
| 2024-12-10 | Iniziato | Jefferies | Buy |
| 2024-05-01 | Ripresa | Craig Hallum | Buy |
| 2023-12-29 | Reiterato | BTIG Research | Buy |
| 2023-08-21 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-02-24 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2023-02-01 | Aggiornamento | Needham | Hold → Buy |
| 2022-08-26 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-22 | Downgrade | Needham | Buy → Hold |
| 2022-06-03 | Iniziato | Piper Sandler | Overweight |
| 2022-03-29 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-03-29 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | Ripresa | Stephens | Overweight |
| 2021-12-16 | Iniziato | Cowen | Outperform |
| 2021-11-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | Iniziato | Goldman | Buy |
| 2021-02-25 | Ripresa | Needham | Buy |
| 2021-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-12-11 | Ripresa | BTIG Research | Buy |
| 2020-10-28 | Reiterato | Needham | Buy |
| 2020-09-09 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-28 | Iniziato | Guggenheim | Buy |
| 2020-07-29 | Reiterato | Needham | Buy |
| 2020-06-25 | Iniziato | BofA/Merrill | Buy |
| 2020-04-21 | Ripresa | Stephens | Overweight |
| 2020-03-02 | Ripresa | Craig Hallum | Buy |
| 2020-02-28 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-05-01 | Reiterato | Needham | Buy |
| 2019-03-29 | Reiterato | Needham | Buy |
| 2019-01-03 | Iniziato | Needham | Buy |
| 2018-10-24 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | Iniziato | Leerink Partners | Outperform |
| 2018-05-02 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2017-08-24 | Iniziato | Gabelli & Co | Buy |
| 2016-12-15 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Neogenomics Inc Borsa (NEO) Ultime notizie
Here’s Alger Weatherbie Specialized Growth Fund’s Comment on NeoGenomics (NEO) - Yahoo
NeoGenomics (NEO) Tops Q4 Earnings Estimates - MSN
Guidance Update: How does NeoGenomics Inc perform in inflationary periods2025 Technical Patterns & Safe Capital Growth Stock Tips - خودرو بانک
Sectors Review: Can FANG reach resistance levels soonMarket Volume Summary & Weekly Watchlist of Top Performers - khodrobank.com
Big Money Moves: What is NeoGenomics Inc. s debt to equity ratioTrade Analysis Report & AI Driven Price Predictions - خودرو بانک
Market Trends: Is Centerra Gold Inc. a turnaround storyRate Cut & AI Optimized Trade Strategies - khodrobank.com
Published on: 2025-09-19 15:28:49 - خودرو بانک
NeoGenomics (NASDAQ:NEO) Stock Price Down 3.8%Here's Why - MarketBeat
NeoGenomics rallies after court win in Natera patent dispute - MSN
Options Flow: Can Fenbo Holdings Limited scale operations efficientlyEarnings Performance Report & Smart Swing Trading Techniques - khodrobank.com
Risk Hedge: Why is NeoGenomics Inc. stock going up2025 Trade Ideas & Free Community Consensus Stock Picks - خودرو بانک
FOMO Trade: What is Gain Therapeutics Incs 5 year growth outlookJuly 2025 Movers & Low Risk High Reward Trade Ideas - khodrobank.com
TD Cowen Issues Positive Forecast for NeoGenomics (NASDAQ:NEO) Stock Price - MarketBeat
Can NeoGenomics Inc keep up with sector leadersMarket Activity Recap & Real-Time Volume Spike Alerts - خودرو بانک
Aug Gainers: What is NeoGenomics Incs 5 year growth outlook2025 Performance Recap & Free Technical Pattern Based Buy Signals - khodrobank.com
NeoGenomics (NASDAQ:NEO) Stock Price Up 8.5%Here's What Happened - MarketBeat
Weekly Trades: Is NeoGenomics Inc stock undervalued right nowQuarterly Performance Summary & Real-Time Stock Entry Alerts - خودرو بانک
Analyst Calls: Does NeoGenomics Inc. have a sustainable dividendQuarterly Trade Review & Growth Oriented Trade Recommendations - خودرو بانک
Sell Signal: Can NeoGenomics Inc stock outperform in a bear marketNew Guidance & Free Technical Confirmation Trade Alerts - خودرو بانک
Sectors Review: Why is NeoGenomics Inc stock going upEarnings Risk Summary & Consistent Growth Equity Picks - خودرو بانک
Is Network 1 Technologies Inc. forming bullish engulfing patternsPortfolio Growth Summary & Precise Buy Zone Tips - خودرو بانک
Bond Watch: Will NeoGenomics Inc stock hit new highs in YEARGlobal Markets & Growth Focused Entry Point Reports - خودرو بانک
RSI Check: Is NeoGenomics Inc stock a good pick for beginnersJuly 2025 News Drivers & Technical Buy Zone Confirmation - خودرو بانک
Volume Report: Should you buy the dip on NeoGenomics IncMarket Trend Report & Fast Entry and Exit Trade Plans - خودرو بانک
Bear Alert: Is NeoGenomics Inc forming bullish engulfing patterns2025 Top Decliners & Fast Moving Trade Plans - خودرو بانک
Exact Sciences’ Cancerguard™ Launch Could Be a Game Changer for NeoGenomics (NEO) - Sahm
Risk Off: Does BWMX meet Warren Buffett’s criteriaPortfolio Return Summary & Reliable Entry Point Alerts - خودرو بانک
Insider Buy: What is the Moat Score of Banzai International Inc2025 Volume Leaders & Weekly Momentum Stock Picks - خودرو بانک
Fred Alger Management LLC Reduces Holdings in NeoGenomics, Inc. $NEO - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc.NEO - FinancialContent
Intraday pattern recognizer results for NeoGenomics Inc.July 2025 Spike Watch & Growth Focused Stock Reports - Newser
Technical signs of recovery in NeoGenomics Inc.Earnings Growth Summary & Reliable Price Breakout Signals - Newser
Neogenomics stock price target raised to $12 by TD Cowen on new product outlook - Investing.com Canada
Applying sector rotation models to NeoGenomics Inc.Trade Entry Summary & Community Verified Watchlist Alerts - Newser
Has NeoGenomics Inc. found a price floorWeekly Profit Analysis & Weekly Chart Analysis and Trade Guides - Newser
Why NeoGenomics (NEO) Shares Are Falling Today - TradingView
Why Natera (NTRA) Shares Are Falling Today - FinancialContent
What are NeoGenomics Inc.’s recent SEC filings showing2025 Volume Leaders & Safe Capital Growth Tips - Lancaster City Council
Northern Trust Corp Cuts Stock Position in NeoGenomics, Inc. $NEO - MarketBeat
Price Floor Holding on NeoGenomics Inc. — Rebound PossibleJuly 2025 PostEarnings & Low Volatility Stock Recommendations - beatles.ru
What are the future prospects of NeoGenomics Inc.Swing Trade & Scalable Portfolio Growth Methods - beatles.ru
NeoGenomics (NASDAQ:NEO) Shares Down 5.2%Should You Sell? - MarketBeat
Should value investors consider NeoGenomics Inc.2025 Key Lessons & Fast Moving Stock Trade Plans - beatles.ru
Tech Rally: Why is NeoGenomics Inc. stock going upEarnings Overview Summary & Verified Momentum Stock Watchlist - classian.co.kr
NeoGenomics (NASDAQ:NEO) Given New $11.00 Price Target at Stephens - MarketBeat
First Light Asset Management LLC Has $57.35 Million Stock Position in NeoGenomics, Inc. $NEO - MarketBeat
Institution Moves: Will NeoGenomics Inc. benefit from geopolitical trendsMarket Movers & Fast Exit and Entry Strategy Plans - خودرو بانک
Hsbc Holdings PLC Lowers Position in NeoGenomics, Inc. $NEO - Defense World
What data driven models say about NeoGenomics Inc.’s future2025 Institutional Moves & Reliable Breakout Forecasts - Newser
Ranking NeoGenomics Inc. among high performing stocks via toolsGold Moves & Breakout Confirmation Trade Signals - Newser
Is now a turning point for NeoGenomics Inc.Market Volume Report & Long Hold Capital Preservation Tips - Newser
Neogenomics Inc Azioni (NEO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):